Posts tagged as: SP500 end of day back to homepage

Stocks Rally Monday on Budget Talks Stocks Rally Monday on Budget Talks(0)

Stocks on Wall Street stampeded ahead on Monday to escalate a rally that started last Friday on high hopes that Washington D.C. is going to sing “kumbaya” together and work out an answer to the so-called fiscal cliff that is coming at the start of 2013 that will cost the economy more than $600 billion in spending cuts and tax hikes. Investors believing that a budget deal will be struck by the end of 2012 lofted all three exchanges the most since September 6 when European Central Bank President Mario Draghi announced his plans of “whatever it takes” to save the euro.

Overseas, markets rallied as well in part on the back on the fiscal cliff optimism in the States and also because of an expected tentative approval tomorrow Read More

Stocks Continue Downward Plight Stocks Continue Downward Plight(2)

US stocks continued their downward plight on Thursday, adding to a string of losses amid a lack of confidence lawmakers can stop the economy from going over the so-called fiscal cliff and data showing the 17-country euro-zone has fallen back into recession. Read More

Stocks Soar to End First Half of 2012 Stocks Soar to End First Half of 2012(0)

U.S. stocks soared Friday, with the Dow jumping more than 200 points, as investors cheered a deal among European leaders to help struggling euro-zone banks. Read More

Stocks on Wall Street Mixed at Friday’s Closing Bell(0)

In New York, stocks were mixed Friday, with the Dow and S&P holding near the highest levels since 2008, as investors digested reports on consumer sentiment and home sales.

The Dow Jones Industrials were negative 1.74 points to end the day and the week at 12,983, after briefly being perched above the psychologically-important 13,000 mark. Read More

Stay Informed

Receive the OTCS Newsletter *


* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

© 2011 Viper Enterprises, LLC. All rights reserved.